Abstract
The gastrointestinal absorption of quinidine from three commercially available tablet products has been compared to that from a quinidine sulfate solution previously found to have 70% of the systematic availability of an intravenous dose. Quinidine gluconate solution was included in the study to compare the absorption characteristics of the two quinidine salts. The tablets were given in a counterbalanced sequence preceded by one quinidine solution and followed by the other in a crossover design. The three tablets proved to be equivalent to one another with respect to extent and rate of absorption. The absorption properties of the two solutions were indistinguishable. The tablets were equivalent to the solutions in extent but not in rate of absorption.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
T. W. Guentert, N. H. G. Holford, P. E. Coates, R. A. Upton, and S. Riegelman. Quinidine pharmacokinetics in man—Choice of a disposition model and absolute bioavailability studies.J. Pharmacokin. Biopharm. 7:315–330 (1979).
D. J. Greenblatt, H. J. Pfeifer, H. R. Ochs, K. Franke, D. S. McLaughlin, T. W. Smith, and J. Koch-Weser. Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration.J. Pharmacol. Exp. Ther. 202:365–378 (1977).
H. R. Ochs, D. J. Greenblatt, E. Woo, K. Franke, H. J. Pfeifer, and W. Smith. Single and multiple dose pharmacokinetics of oral quinidine sulfate and gluconate.Am. J. Cardiol. 41:770–777 (1978).
T. W. Guentert, P. E. Coates, R. A. Upton, D. L. Combs, and S. Riegelman. Determination of quinidine and its major metabolites by high-performance liquid chromatography.J. Chromatogr. 162:59–70 (1979).
K. C. Yeh, and K. C. Kwan. A comparison of numerical integrating algorithms by trapezoidal, Lagrange and spline approximation.J. Pharmacokin. Biopharm. 6:79–98 (1978).
N. Holford. “DRUGFUN.” In (H. M. Perry and J. J. Wood, (eds.)),Public Procedures Notebook, Bolt Beranek and Newman Inc., Cambridge, Mass., 1979.
H. Akaike. A new look at the statistical model identification,IEEE Tr. Automat. Contr. 19:716–723 (1973).
H. Akaike. An information criterion (AIC).Math. Sci. 14:5–9 (1976).
K. Yamaoka, T. Nakagawa, and T. Uno. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equationsJ. Pharmacokin. Biopharm. 6:165–175 (1978).
A Bostrom. “RMEAS,” a program for repeated measures analysis of variance, Available through Computer Center University of California, San Francisco.
J. Neter and W. Wassermann.Applied Linear Statistical Models. Richard D. Irwin Inc., Homewood, Ill., 1974, pp. 473–482.
C. W. Dunnett. A multiple comparison procedure for comparing several treatments with a control.J. Am. Stat. Assoc. 50:1096–1121 (1955).
C. W. Dunnett. New tables for multiple comparisons with a control.Biometrics 20:482–491 (1964).
D. E. Drayer, K. Restivo, and M. M. Reidenberg. Specific determination of quinidine and (3S)-3-hydroxyquinidine in human serum by high-pressure liquid chromatography.J. Lab. Clin. Med. 90:816–822 (1977).
T. W. Guentert and S. Riegelman. Specificity of quinidine determination methods.Clin. Chem. 24:2065–2066 (1978).
C. T. Ueda, B. J. Williamson, and B. S. Dzindzio. Absolute quinidine bioavailability.Clin. Pharmacol. Ther. 20:260–265 (1976).
K. M. Kessler, R. C. Leech, and J. F. Spann. Blood collection techniques, heparin and quinidine protein binding.Clin. Pharmacol. Ther. 25:204–210 (1979).
W. J. Dixon.Biomedical Computer Programs P-Series, University of California Press, Los Angeles, 1977.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Guentert, T.W., Upton, R.A., Holford, N.H.G. et al. Gastrointestinal absorption of quinidine from some solutions and commercial tablets. Journal of Pharmacokinetics and Biopharmaceutics 8, 243–255 (1980). https://doi.org/10.1007/BF01059645
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01059645